Estados financieros detallados de IN8bio, Inc. (INAB): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Cuenta de Resultados (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | $96000 | $96000 | 0 | 0 | 0 | $2.5M | 0 | $2.5M |
| Beneficio Bruto | -$96000 | -$96000 | 0 | 0 | 0 | -$2.5M | 0 | -$2.5M |
| I+D | $581000 | $2.4M | $5.4M | $7.3M | $14.1M | $16.8M | $17.0M | $10.2M |
| Generales y Administrativos | $1.4M | $2.7M | $3.2M | $7.3M | $14.5M | $13.5M | $12.6M | $9.7M |
| Gastos Operativos | $2.0M | $5.1M | $8.6M | $14.7M | $28.5M | $27.8M | $30.4M | $17.4M |
| Beneficio Operativo | -$2.0M | -$5.1M | -$8.6M | -$14.7M | -$28.5M | -$30.3M | -$30.4M | -$19.9M |
| EBITDA | -$2.0M | -$5.0M | -$8.5M | -$13.9M | -$27.4M | -$27.5M | -$26.9M | -$16.9M |
| Gastos por Intereses | $14000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$2.1M | -$5.1M | -$8.6M | -$14.7M | -$28.5M | -$30.0M | -$30.4M | -$19.4M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$2.1M | -$5.1M | -$8.6M | -$14.7M | -$28.5M | -$30.0M | -$30.4M | -$19.4M |
| BPA | $-3.89 | $-9.16 | $-16.03 | $-23.41 | $-40.81 | $-30.14 | $-17.05 | $-4.44 |
| BPA Diluido | $-3.89 | $-9.16 | $-16.03 | $-23.41 | $-40.81 | $-30.14 | $-17.05 | $-4.44 |
| Acciones en Circulación (Diluidas) | $645151 | $645151 | $645151 | $626041 | $698931 | $995497 | $1.8M | $4.4M |
Balance (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $5.0M | $610000 | $18.0M | $37.0M | $18.2M | $21.3M | $11.1M | $27.1M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | $30000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventario | $15000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $5.1M | $763000 | $18.1M | $39.0M | $22.2M | $24.6M | $12.6M | $27.9M |
| Inmovilizado Material | $795000 | $274000 | $186000 | $2.8M | $10.3M | $8.6M | $7.8M | $4.0M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | $126000 | 0 | 0 | 0 |
| Activos Totales | $5.9M | $1.1M | $20.9M | $42.2M | $33.0M | $33.7M | $20.9M | $32.3M |
| Cuentas por Pagar | $419000 | $560000 | $620000 | $395000 | $2.1M | $924000 | $389000 | $309000 |
| Deuda a Corto | 0 | 0 | $174000 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $419000 | $647000 | $2.6M | $2.3M | $5.8M | $5.4M | $3.1M | $3.2M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $1.6M |
| Pasivos Totales | $1.2M | $1.5M | $2.6M | $4.0M | $10.3M | $8.8M | $6.5M | $4.7M |
| Reservas | -$4.3M | -$9.5M | -$18.0M | -$32.7M | -$61.2M | -$91.2M | -$121.7M | -$141.1M |
| Patrimonio Neto | $4.6M | -$346000 | $18.3M | $38.2M | $22.7M | $24.9M | $14.5M | $27.6M |
| Deuda Total | 0 | 0 | $174000 | $2.4M | $5.9M | $4.9M | $5.0M | $2.8M |
| Deuda Neta | -$5.0M | -$610000 | -$17.8M | -$34.6M | -$12.3M | -$16.4M | -$6.1M | -$24.3M |
| Capital Circulante | $4.7M | $116000 | $15.6M | $36.7M | $16.4M | $19.2M | $9.5M | $24.7M |
Flujo de Caja (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Beneficio Neto | -$2.1M | -$5.1M | -$8.6M | -$14.7M | -$28.5M | -$30.0M | -$30.4M | -$19.4M |
| Amortizaciones | $96000 | $96000 | $88000 | $788000 | $1.1M | $2.5M | $2.7M | $1.8M |
| Compensación en Acciones | $31000 | $76000 | $357000 | $2.2M | $3.5M | $4.4M | $5.0M | $3.2M |
| Cambio en Capital Circulante | -$885000 | $93000 | $611000 | -$1.8M | -$170000 | -$204000 | -$1.4M | $1.0M |
| Flujo de Caja Operativo | -$2.8M | -$4.8M | -$7.1M | -$13.5M | -$24.1M | -$23.3M | -$24.1M | -$12.7M |
| Inversiones (CapEx) | -$757000 | -$330000 | 0 | -$309000 | -$3.7M | -$600000 | -$104000 | 0 |
| Adquisiciones | 0 | $686000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$3.5M | -$5.1M | -$7.1M | -$13.8M | -$27.8M | -$23.9M | -$24.3M | -$12.7M |
Crecimiento y Márgenes (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Crecimiento Beneficio Neto (anual) | -146.7% | -66.7% | -71.2% | -94.6% | -5.2% | -1.4% | +36.1% | |
| Crecimiento BPA (anual) | -135.5% | -75.0% | -46.0% | -74.3% | +26.1% | +43.4% | +74.0% | |
| Cambio en Acciones (anual) | +0.0% | +0.0% | -3.0% | +11.6% | +42.4% | +79.3% | +145.1% | |
| Crecimiento FCF (anual) | -45.5% | -39.0% | -93.7% | -101.4% | +14.0% | -1.3% | +47.6% | |
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| FCF por Acción | $-5.47 | $-7.95 | $-11.06 | $-22.07 | $-39.81 | $-24.05 | $-13.59 | $-2.91 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $645151 | $645151 | $645151 | $626041 | $698931 | $995497 | $1.8M | $4.4M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Ratios Clave (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| P/E | -77.12 | -32.75 | -18.71 | -5.63 | -1.70 | -1.37 | -0.45 | -0.53 |
| P/VC | 41.65 | -559.38 | 10.56 | 2.16 | 2.13 | 1.65 | 0.95 | 0.37 |
| P/V | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Margen Bruto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Operativo | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Neto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Empresas relacionadas: ACXP · APRE · APVO · BCDA · GLTO · HCWB · KPRX
Explorar sector: Healthcare · Biotechnology
Más secciones de INAB: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones